Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.31 trillion and total revenue of $116.09 billion.
Market Cap
1.31T
Revenue
116.09B
Profits
-38.25B
PE Ratio
n/a
Profit Margin
-32.95%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 129.45B | 0.47% | 899,699 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.70B | 1.70% | 704,524 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 69.04B | 12.27% | 21,043,688 | 2.23B |
| 4 | ARGX | argenx SE | 62.26B | -0.21% | 231,641 | 5.32B |
| 5 | ONC | BeOne Medicines AG | 41.58B | 4.23% | 488,977 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 41.32B | 0.95% | 1,888,787 | - |
| 7 | RPRX | Royalty Pharma plc | 33.60B | 0.05% | 3,231,883 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.69B | 1.99% | 1,152,872 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.16B | -1.96% | 5,620,749 | 7.53M |
| 10 | INSM | Insmed Incorporated | 26.42B | 0.83% | 1,812,278 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.27B | -0.53% | 1,270,531 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.62B | 2.02% | 801,207 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.72B | -0.14% | 1,577,451 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.67B | 0.30% | 499,159 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 15.60B | 0.37% | 810,383 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.18B | -1.95% | 2,102,578 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.48B | -5.32% | 5,780,847 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.02B | -0.05% | 3,155,883 | 713.07M |
| 19 | HALO | Halozyme Therapeutics, Inc. | 12.65B | -0.89% | 2,925,653 | 1.66B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 12.40B | 0.19% | 1,877,004 | 3.41B |
| 21 | CORT | Corcept Therapeutics Incorporated | 12.30B | 3.15% | 1,279,964 | 830.81M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.06B | -1.80% | 186,146 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.36B | 0.14% | 3,730,437 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 10.76B | -1.10% | 543,356 | 776.57M |
| 25 | TWST | Twist Bioscience Corporation | 10.40B | -0.69% | 2,238,688 | 431.80M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.88B | -0.84% | 210,244 | 440.48M |
| 27 | KYMR | Kymera Therapeutics, Inc. | 9.78B | -0.07% | 636,820 | 105.00M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.72B | 3.47% | 2,347,709 | 669.50M |
| 29 | CYTK | Cytokinetics, Incorporated | 9.39B | -1.77% | 1,603,380 | 67.67M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.38B | 1.38% | 735,080 | 281.99M |
| 31 | ABVX | ABIVAX Société Anonyme | 9.06B | -1.51% | 974,607 | 5.80M |
| 32 | IBRX | ImmunityBio, Inc. | 8.96B | -0.35% | 12,238,176 | 165.79M |
| 33 | PCVX | Vaxcyte, Inc. | 8.77B | 1.36% | 1,124,393 | - |
| 34 | CAI | Caris Life Sciences, Inc. | 8.66B | 2.23% | 6,146,707 | 989.61M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.34B | -0.03% | 526,669 | 7.46M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 8.11B | 1.97% | 1,402,210 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 8.11B | 0.51% | 2,141,095 | 799.54M |
| 38 | IMVT | Immunovant, Inc. | 7.68B | 0.62% | 1,031,384 | - |
| 39 | IONS | Ionis Pharmaceuticals, Inc. | 7.46B | 1.04% | 4,521,341 | 874.09M |
| 40 | BLTE | Belite Bio, Inc | 6.98B | 1.43% | 119,757 | - |
| 41 | CGON | CG Oncology, Inc. | 6.94B | 4.86% | 1,061,934 | 6.23M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.80B | 1.15% | 598,513 | 239.92M |
| 43 | ORKA | Oruka Therapeutics, Inc. | 6.18B | -1.66% | 1,163,701 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.97B | 0.19% | 653,158 | 618.07M |
| 45 | TVTX | Travere Therapeutics, Inc. | 5.93B | 0.16% | 1,583,775 | 591.33M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.87B | 3.24% | 2,851,676 | - |
| 47 | LGND | Ligand Pharmaceuticals Incorporated | 5.78B | 2.32% | 226,841 | 290.54M |
| 48 | CRSP | CRISPR Therapeutics AG | 5.64B | 3.13% | 1,814,120 | 13.39M |
| 49 | COGT | Cogent Biosciences, Inc. | 5.55B | 1.59% | 3,415,288 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.45B | -0.17% | 1,043,702 | 1.01B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.40B | -0.35% | 912,544 | 1.90M |
| 52 | DFTX | Definium Therapeutics, Inc. | 5.28B | 1.21% | 2,037,800 | - |
| 53 | ERAS | Erasca, Inc. | 5.26B | 1.83% | 4,151,155 | - |
| 54 | EWTX | Edgewise Therapeutics, Inc. | 4.85B | -1.50% | 1,178,366 | - |
| 55 | MANE | Veradermics, Incorporated | 4.71B | 5.67% | 584,666 | - |
| 56 | IOVA | Iovance Biotherapeutics, Inc. | 4.62B | -0.59% | 13,129,488 | 324.97M |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.56B | -11.50% | 1,705,550 | 148.00K |
| 58 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | -3.28% | 1,351,868 | 1.14B |
| 59 | CELC | Celcuity Inc. | 4.11B | 4.21% | 718,097 | - |
| 60 | ABCL | AbCellera Biologics Inc. | 4.10B | 0.24% | 4,426,943 | 66.17M |
| 61 | RLAY | Relay Therapeutics, Inc. | 3.99B | -3.45% | 3,029,855 | 10.35M |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.81B | -10.17% | 865,929 | 890.79M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.78B | -1.91% | 4,049,378 | 7.50M |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.77B | 2.67% | 2,555,502 | 53.81M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.75B | 1.17% | 544,195 | 234.13M |
| 66 | LEGN | Legend Biotech Corporation | 3.59B | 5.22% | 2,832,446 | 1.27B |
| 67 | ELVN | Enliven Therapeutics, Inc. | 3.58B | -1.17% | 2,281,258 | - |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.51B | 3.86% | 5,086,725 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.40B | -0.81% | 487,092 | 606.33M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.30B | 2.81% | 1,111,193 | 117.00M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.27B | 3.80% | 2,393,673 | 3.60M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | 2.29% | 1,833,705 | 463.98M |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.20B | 0.06% | 3,219,970 | - |
| 74 | QURE | uniQure N.V. | 3.07B | 0.70% | 783,215 | 18.67M |
| 75 | CLDX | Celldex Therapeutics, Inc. | 2.98B | -0.92% | 549,508 | 158.00K |
| 76 | ZLAB | Zai Lab Limited | 2.97B | 2.84% | 1,181,927 | 449.61M |
| 77 | MBX | MBX Biosciences, Inc. | 2.93B | -3.13% | 657,280 | - |
| 78 | IMNM | Immunome, Inc. | 2.85B | 4.59% | 1,180,592 | 4.02M |
| 79 | PGEN | Precigen, Inc. | 2.76B | -1.03% | 3,240,237 | 85.72M |
| 80 | NAMS | NewAmsterdam Pharma Company N.V. | 2.70B | 0.40% | 3,530,570 | 7.12M |
| 81 | NRIX | Nurix Therapeutics, Inc. | 2.64B | -0.12% | 1,367,770 | 36.77M |
| 82 | IRON | Disc Medicine, Inc. | 2.63B | -1.50% | 406,531 | - |
| 83 | GPCR | Structure Therapeutics Inc. | 2.62B | 5.17% | 1,021,509 | - |
| 84 | PHVS | Pharvaris N.V. | 2.53B | -0.96% | 653,687 | - |
| 85 | BEAM | Beam Therapeutics Inc. | 2.52B | 1.24% | 1,703,948 | 156.04M |
| 86 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | 1.03% | 701,824 | - |
| 87 | VERA | Vera Therapeutics, Inc. | 2.47B | 0.74% | 1,204,663 | - |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.45B | 0.19% | 789,297 | 959.90M |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.44B | -1.91% | 1,745,704 | 71.13M |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.30B | -1.04% | 5,641,590 | - |
| 91 | NKTR | Nektar Therapeutics | 2.28B | -0.39% | 766,891 | 54.59M |
| 92 | GENB | Generate Biomedicines, Inc. | 2.23B | 1.40% | 1,393,751 | 26.48M |
| 93 | PVLA | Palvella Therapeutics, Inc. | 2.21B | 1.89% | 123,362 | - |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | -1.72% | 668,199 | 311.51M |
| 95 | OCUL | Ocular Therapeutix, Inc. | 2.19B | - | 2,073,006 | 52.06M |
| 96 | BHVN | Biohaven Ltd. | 2.15B | 4.41% | 3,293,798 | - |
| 97 | NUVB | Nuvation Bio Inc. | 2.13B | 3.76% | 3,027,016 | 169.90M |
| 98 | RXRX | Recursion Pharmaceuticals, Inc. | 2.13B | 3.66% | 37,728,630 | 54.86M |
| 99 | ADMA | ADMA Biologics, Inc. | 2.13B | 4.34% | 2,858,636 | 512.28M |
| 100 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | 0.15% | 1,688,670 | 1.97B |
| 101 | ZBIO | Zenas BioPharma, Inc. | 2.12B | 3.33% | 414,499 | 1.00M |
| 102 | TRVI | Trevi Therapeutics, Inc. | 2.12B | -0.40% | 1,649,385 | - |
| 103 | URGN | UroGen Pharma Ltd. | 2.11B | -0.12% | 482,410 | 188.73M |
| 104 | KOD | Kodiak Sciences Inc. | 2.03B | -0.89% | 666,228 | - |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | 2.66% | 884,548 | 98.34M |
| 106 | VCEL | Vericel Corporation | 2.03B | -1.17% | 402,097 | 306.30M |
| 107 | MESO | Mesoblast Limited | 2.00B | 2.31% | 165,741 | 120.25M |
| 108 | GHRS | GH Research PLC | 1.92B | -1.17% | 131,081 | - |
| 109 | LKFT | Lakefront Biotherapeutics NV | 1.91B | 3.64% | 208,121 | 1.13B |
| 110 | FTRE | Fortrea Holdings Inc. | 1.90B | 0.45% | 1,051,221 | 2.68B |
| 111 | RAPP | Rapport Therapeutics, Inc. | 1.90B | -1.95% | 616,966 | 20.00M |
| 112 | ZYME | Zymeworks Inc. | 1.90B | 0.90% | 512,923 | 37.13M |
| 113 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.86B | 2.87% | 2,300,321 | 208.78M |
| 114 | XNCR | Xencor, Inc. | 1.86B | 1.25% | 1,389,704 | 104.97M |
| 115 | VIR | Vir Biotechnology, Inc. | 1.84B | 2.64% | 1,354,959 | 303.23M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.81B | -1.34% | 720,006 | 27.59M |
| 117 | SEPN | Septerna, Inc. | 1.80B | -0.39% | 252,382 | 98.88M |
| 118 | COAG | Hemab Therapeutics Holdings, Inc. | 1.77B | -7.82% | 556,552 | - |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.76B | -0.31% | 989,124 | - |
| 120 | NBTX | Nanobiotix S.A. | 1.73B | 4.67% | 94,527 | 38.27M |
| 121 | NVAX | Novavax, Inc. | 1.72B | 2.97% | 6,135,454 | 413.80M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.71B | 0.66% | 3,738,743 | 59.51M |
| 123 | ABSI | Absci Corporation | 1.69B | 1.76% | 4,559,441 | 1.56M |
| 124 | IMCR | Immunocore Holdings plc | 1.66B | 0.56% | 265,975 | 430.78M |
| 125 | INBX | Inhibrx Biosciences, Inc. | 1.65B | 2.46% | 249,114 | 1.30M |
| 126 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | 0.40% | 1,556,307 | 5.49M |
| 127 | ANAB | AnaptysBio, Inc. | 1.63B | -0.51% | 524,392 | 232.39M |
| 128 | SNDX | Syndax Pharmaceuticals, Inc. | 1.61B | 2.55% | 2,108,262 | 252.25M |
| 129 | BRVE | Braveheart Bio, Inc. | 1.61B | -14.32% | 1,571,178 | - |
| 130 | KLRA | Kailera Therapeutics, Inc. | 1.55B | -6.55% | 1,050,487 | - |
| 131 | KARD | Kardigan, Inc. | 1.52B | -2.04% | 724,452 | - |
| 132 | INVA | Innoviva, Inc. | 1.52B | -0.47% | 688,519 | 440.00M |
| 133 | KRSA | Korsana Biosciences, Inc. | 1.51B | -5.09% | 21,670 | - |
| 134 | AAPG | Ascentage Pharma Group International | 1.49B | 5.31% | 17,353 | 94.61M |
| 135 | AVBP | ArriVent BioPharma, Inc. | 1.47B | 2.91% | 936,994 | - |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.46B | -2.78% | 315,352 | - |
| 137 | RARE | Ultragenyx Pharmaceutical Inc. | 1.44B | 0.96% | 5,270,363 | 717.00M |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.43B | 1.71% | 412,702 | - |
| 139 | DMRA | Damora Therapeutics, Inc. | 1.41B | 1.15% | 618,450 | - |
| 140 | AVLN | Avalyn Pharma Inc. | 1.40B | 0.32% | 177,298 | - |
| 141 | LTGO | Latigo Biotherapeutics, Inc. | 1.40B | -6.39% | 411,907 | - |
| 142 | TRAX | First Tracks Biotherapeutics, Inc. | 1.39B | 1.01% | 661,250 | - |
| 143 | LBRX | LB Pharmaceuticals Inc | 1.39B | 1.22% | 310,154 | - |
| 144 | SVRA | Savara Inc. | 1.39B | 1.49% | 1,311,922 | - |
| 145 | CGEM | Cullinan Therapeutics, Inc. | 1.37B | 1.28% | 763,868 | - |
| 146 | OMER | Omeros Corporation | 1.34B | 3.47% | 1,055,570 | 38.42M |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.31B | -0.94% | 835,960 | - |
| 148 | VOR | Vor Biopharma Inc. | 1.30B | 2.29% | 1,864,070 | - |
| 149 | MGTX | MeiraGTx Holdings plc | 1.26B | -1.28% | 1,286,204 | 397.50M |
| 150 | MAZE | Maze Therapeutics, Inc. | 1.24B | -0.58% | 516,967 | 20.00M |
| 151 | REPL | Replimune Group, Inc. | 1.21B | -1.53% | 1,461,725 | - |
| 152 | ANRO | Alto Neuroscience, Inc. | 1.20B | 1.19% | 357,796 | - |
| 153 | IMTX | Immatics N.V. | 1.19B | 1.16% | 305,294 | 47.65M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.19B | -2.06% | 614,224 | 10.06M |
| 155 | SPTX | Seaport Therapeutics, Inc. | 1.13B | -1.26% | 234,265 | - |
| 156 | MNKD | MannKind Corporation | 1.13B | -1.13% | 4,527,405 | 393.63M |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 1.10B | -5.41% | 245,657 | 99.00K |
| 158 | APMD | Apnimed, Inc. | 1.09B | -9.59% | 1,511,002 | 115.12M |
| 159 | OBX | Obsidian Therapeutics, Inc. | 1.07B | -2.37% | 1,104,841 | - |
| 160 | MLTX | MoonLake Immunotherapeutics | 1.07B | 1.29% | 1,220,021 | - |
| 161 | JBIO | Jade Biosciences, Inc. | 1.06B | -1.18% | 528,697 | - |
| 162 | GLUE | Monte Rosa Therapeutics, Inc. | 1.05B | 1.07% | 1,128,236 | 28.73M |
| 163 | CRVS | Corvus Pharmaceuticals, Inc. | 1.04B | -1.11% | 939,766 | - |
| 164 | JANX | Janux Therapeutics, Inc. | 1.04B | 2.53% | 701,809 | 24.00M |
| 165 | KURA | Kura Oncology, Inc. | 1.03B | -1.11% | 1,763,230 | 77.23M |
| 166 | ALMS | Alumis Inc. | 1.02B | 1.67% | 2,433,339 | 7.40M |
| 167 | ANL | Adlai Nortye Group Ltd. | 1.00B | -1.08% | 92,541 | 18.06M |
| 168 | HELP | Cybin Inc. | 998.00M | 10.43% | 2,873,413 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 989.24M | -0.20% | 4,562,544 | 181.72M |
| 170 | SLBT | SL Science Holding Limited | 980.86M | - | 56,608 | 3.27M |
| 171 | ATTO | Attovia Therapeutics, Inc. | 972.37M | -3.79% | 460,836 | 1.80M |
| 172 | SGP | SpyGlass Pharma, Inc. | 935.21M | -3.85% | 174,295 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 928.02M | - | 2,005,010 | - |
| 174 | SLDB | Solid Biosciences Inc. | 915.70M | -4.15% | 1,170,806 | - |
| 175 | LXRX | Lexicon Pharmaceuticals, Inc. | 907.71M | -0.49% | 2,506,458 | 41.47M |
| 176 | IMMX | Immix Biopharma, Inc. | 892.10M | -0.24% | 1,329,527 | - |
| 177 | TBPH | Theravance Biopharma, Inc. | 885.21M | 0.18% | 667,293 | 104.31M |
| 178 | RIGL | Rigel Pharmaceuticals, Inc. | 879.63M | 0.96% | 164,837 | 276.79M |
| 179 | ETRA | Electra Therapeutics, Inc. | 873.72M | 5.06% | 813,122 | - |
| 180 | ARDX | Ardelyx, Inc. | 872.16M | 2.34% | 2,834,103 | 450.89M |
| 181 | AVTX | Avalo Therapeutics, Inc. | 867.20M | -2.41% | 542,638 | 59.00K |
| 182 | FTH | Faeth Therapeutics, Inc. | 860.23M | -3.51% | 379,103 | - |
| 183 | CADL | Candel Therapeutics, Inc. | 857.77M | 3.32% | 1,086,919 | - |
| 184 | IVA | Inventiva S.A. | 850.92M | -3.44% | 1,369,023 | 7.94M |
| 185 | OLMA | Olema Pharmaceuticals, Inc. | 842.60M | -1.93% | 1,070,329 | - |
| 186 | FDMT | 4D Molecular Therapeutics, Inc. | 841.92M | 0.13% | 699,175 | 92.01M |
| 187 | WVE | Wave Life Sciences, Inc. | 838.44M | -2.18% | 2,372,976 | 65.37M |
| 188 | GERN | Geron Corporation | 835.22M | - | 5,897,021 | 204.56M |
| 189 | ACHV | Achieve Life Sciences, Inc. | 828.37M | 0.88% | 1,006,915 | - |
| 190 | BLSM | BlossomHill Therapeutics, Inc. | 821.25M | 4.12% | 291,798 | - |
| 191 | ACRS | Aclaris Therapeutics, Inc. | 819.90M | 1.27% | 1,521,383 | 8.22M |
| 192 | ANNX | Annexon, Inc. | 800.02M | -0.24% | 4,187,449 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 787.83M | -1.59% | 364,869 | 109.82M |
| 194 | DSGN | Design Therapeutics, Inc. | 785.40M | 2.53% | 506,417 | - |
| 195 | CLYM | Climb Bio, Inc. | 783.43M | -2.92% | 1,259,911 | - |
| 196 | PHAR | Pharming Group N.V. | 753.32M | 2.46% | 218,383 | 366.48M |
| 197 | SLN | Silence Therapeutics plc | 737.56M | 0.41% | 419,364 | 615.00K |
| 198 | VSTM | Verastem, Inc. | 723.60M | 7.39% | 2,800,861 | 87.53M |
| 199 | DBVT | DBV Technologies S.A. | 723.58M | -2.02% | 131,426 | 5.04M |
| 200 | NVCT | Nuvectis Pharma, Inc. | 716.14M | -0.09% | 166,367 | - |
| 201 | MDXG | MiMedx Group, Inc. | 701.11M | 0.84% | 915,903 | 355.17M |
| 202 | CBIO | Crescent Biopharma, Inc. | 695.52M | -3.79% | 375,758 | 11.88M |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 693.01M | 0.52% | 714,500 | 136.07M |
| 204 | SGMT | Sagimet Biosciences Inc. | 671.31M | -2.61% | 698,965 | - |
| 205 | OABI | OmniAb, Inc. | 665.89M | 2.46% | 1,364,401 | 38.46M |
| 206 | AURA | Aura Biosciences, Inc. | 659.56M | -1.24% | 819,096 | - |
| 207 | NGNE | Neurogene Inc. | 651.77M | 1.50% | 325,533 | 925.00K |
| 208 | MNPR | Monopar Therapeutics Inc. | 642.49M | -0.78% | 89,235 | - |
| 209 | ALT | Altimmune, Inc. | 636.07M | 0.62% | 3,523,049 | 31.00K |
| 210 | OCS | Oculis Holding AG | 625.96M | - | 201,824 | 1.45M |
| 211 | VALN | Valneva SE | 620.56M | 0.91% | 18,939 | 163.30M |
| 212 | STTK | Shattuck Labs, Inc. | 613.22M | 1.66% | 1,037,074 | 1.00M |
| 213 | MPLT | MapLight Therapeutics, Inc. | 605.78M | -0.18% | 542,857 | - |
| 214 | CRMD | CorMedix Inc. | 605.63M | 0.65% | 505,623 | 462.25M |
| 215 | CTMX | CytomX Therapeutics, Inc. | 601.40M | - | 2,331,035 | 18.30M |
| 216 | DRUG | Bright Minds Biosciences Inc. | 593.40M | -2.49% | 91,627 | - |
| 217 | PHAT | Phathom Pharmaceuticals, Inc. | 591.75M | -0.40% | 898,701 | 239.66M |
| 218 | ALLO | Allogene Therapeutics, Inc. | 583.88M | - | 5,992,359 | 4.64M |
| 219 | AGMB | AgomAb Therapeutics NV | 576.20M | -3.86% | 85,403 | - |
| 220 | EPRX | Eupraxia Pharmaceuticals Inc. | 568.75M | 0.70% | 313,656 | - |
| 221 | PRME | Prime Medicine, Inc. | 567.51M | 2.24% | 2,946,303 | 4.07M |
| 222 | ARVN | Arvinas, Inc. | 542.71M | 0.12% | 639,834 | 316.70M |
| 223 | DNA | Ginkgo Bioworks Holdings, Inc. | 537.38M | 1.27% | 1,653,349 | 132.42M |
| 224 | PROK | ProKidney Corp. | 536.62M | -7.07% | 1,772,452 | 818.00K |
| 225 | SCTX | Scribe Therapeutics Inc. | 531.03M | -15.00% | 528,812 | 33.30M |
| 226 | OVID | Ovid Therapeutics Inc. | 529.26M | 0.74% | 1,183,517 | 1.58M |
| 227 | TECX | Tectonic Therapeutic, Inc. | 520.60M | -1.37% | 131,793 | - |
| 228 | RGNX | REGENXBIO Inc. | 520.18M | -1.87% | 1,115,691 | 174.48M |
| 229 | ASMB | Assembly Biosciences, Inc. | 517.97M | 1.88% | 211,868 | 74.85M |
| 230 | CAPR | Capricor Therapeutics, Inc. | 517.44M | -1.77% | 2,419,019 | 11.13M |
| 231 | AUTL | Autolus Therapeutics plc | 516.36M | - | 1,101,434 | 117.39M |
| 232 | ENTX | Entera Bio Ltd. | 512.50M | - | 294,682 | 42.00K |
| 233 | CTNM | Contineum Therapeutics, Inc. | 509.77M | 0.15% | 638,395 | - |
| 234 | PBYI | Puma Biotechnology, Inc. | 495.04M | -0.10% | 217,540 | 231.24M |
| 235 | PRLD | Prelude Therapeutics Incorporated | 484.08M | -3.49% | 392,656 | 22.42M |
| 236 | EIKN | Eikon Therapeutics, Inc. | 478.28M | -1.34% | 463,784 | - |
| 237 | TTRX | Turn Therapeutics Inc. | 456.95M | 2.68% | 172,861 | - |
| 238 | RLMD | Relmada Therapeutics, Inc. | 443.75M | 0.97% | 552,734 | - |
| 239 | KYTX | Kyverna Therapeutics, Inc. | 440.33M | -0.14% | 678,460 | - |
| 240 | VOGX | Vogenx, Inc. | 438.23M | -9.23% | 245,845 | - |
| 241 | PRTA | Prothena Corporation plc | 436.88M | -0.82% | 363,080 | 54.53M |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 435.51M | 1.88% | 440,070 | - |
| 243 | EDIT | Editas Medicine, Inc. | 434.63M | 4.81% | 2,490,531 | 47.01M |
| 244 | IRD | Opus Genetics, Inc. | 434.28M | 0.77% | 1,980,713 | 9.86M |
| 245 | SPRY | ARS Pharmaceuticals, Inc. | 432.60M | 5.84% | 1,197,896 | 116.93M |
| 246 | ZURA | Zura Bio Limited | 431.23M | 0.90% | 1,111,084 | - |
| 247 | ARCT | Arcturus Therapeutics Holdings Inc. | 417.53M | -8.36% | 1,003,119 | 29.37M |
| 248 | CABA | Cabaletta Bio, Inc. | 417.08M | -3.53% | 4,731,213 | - |
| 249 | INDP | Indaptus Therapeutics, Inc. | 411.72M | -12.96% | 719,416 | - |
| 250 | RZLT | Rezolute, Inc. | 408.47M | 1.82% | 1,082,715 | - |
| 251 | CCCC | C4 Therapeutics, Inc. | 405.98M | -2.65% | 2,050,519 | 35.04M |
| 252 | IKT | Inhibikase Therapeutics, Inc. | 400.56M | -4.35% | 365,986 | 1.00 |
| 253 | LRMR | Larimar Therapeutics, Inc. | 399.79M | 1.06% | 579,330 | - |
| 254 | GALT | Galectin Therapeutics Inc. | 399.36M | 1.80% | 258,353 | - |
| 255 | DMAC | DiaMedica Therapeutics Inc. | 391.50M | 5.99% | 281,821 | - |
| 256 | VTVT | vTv Therapeutics Inc. | 388.90M | -1.57% | 22,686 | 36.84M |
| 257 | ARTV | Artiva Biotherapeutics, Inc. | 382.81M | -9.06% | 629,375 | 251.00K |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 382.58M | 2.73% | 132,859 | 59.22M |
| 259 | BNTC | Benitec Biopharma Inc. | 379.52M | -1.27% | 121,900 | - |
| 260 | OBIO | Orchestra BioMed Holdings, Inc. | 375.66M | 2.80% | 433,189 | 31.98M |
| 261 | AGEN | Agenus Inc. | 375.02M | 6.11% | 1,299,150 | 132.69M |
| 262 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 373.61M | -2.31% | 468,723 | - |
| 263 | RCKT | Rocket Pharmaceuticals, Inc. | 358.96M | -2.97% | 1,355,269 | - |
| 264 | ENTA | Enanta Pharmaceuticals, Inc. | 352.71M | -0.74% | 217,211 | 65.26M |
| 265 | OCGN | Ocugen, Inc. | 349.28M | -2.83% | 4,155,607 | 4.58M |
| 266 | EYPT | EyePoint, Inc. | 346.57M | 4.42% | 3,861,412 | 2.79M |
| 267 | XFOR | X4 Pharmaceuticals, Inc. | 346.52M | -2.37% | 444,354 | 15.85M |
| 268 | EVMN | Evommune, Inc. | 342.96M | -2.07% | 603,019 | 10.00M |
| 269 | IPSC | Century Therapeutics, Inc. | 334.99M | -0.54% | 421,020 | 109.16M |
| 270 | LXEO | Lexeo Therapeutics, Inc. | 334.73M | -2.86% | 854,777 | - |
| 271 | CMPX | Compass Therapeutics, Inc. | 327.76M | -4.21% | 2,987,340 | 850.00K |
| 272 | ABEO | Abeona Therapeutics Inc. | 324.23M | 1.80% | 1,012,998 | 25.52M |
| 273 | IFRX | InflaRx N.V. | 312.42M | 1.44% | 345,138 | -11.54K |
| 274 | QTTB | Q32 Bio Inc. | 311.69M | -0.66% | 359,558 | 53.74M |
| 275 | VNDA | Vanda Pharmaceuticals Inc. | 311.69M | 0.49% | 938,813 | 215.72M |
| 276 | SABS | SAB Biotherapeutics, Inc. | 308.44M | -3.42% | 379,049 | 114.70K |
| 277 | FATE | Fate Therapeutics, Inc. | 303.15M | - | 1,266,653 | 6.49M |
| 278 | IVVD | Invivyd, Inc. | 300.65M | 35.05% | 15,009,513 | 58.37M |
| 279 | CUVL | Clinuvel Pharmaceuticals Limited | 296.34M | -1.53% | 39,258 | 65.05M |
| 280 | PALI | Palisade Bio, Inc. | 294.52M | 6.29% | 3,574,363 | 500.00K |
| 281 | UPB | Upstream Bio, Inc. | 293.85M | 0.47% | 364,033 | 3.16M |
| 282 | VCRE | Vicore Pharma Holding AB (publ) | 290.27M | -1.45% | 116,431 | 412.09K |
| 283 | FULC | Fulcrum Therapeutics, Inc. | 289.93M | 1.06% | 731,368 | 80.00M |
| 284 | IMRX | Immuneering Corporation | 287.26M | -0.89% | 538,873 | - |
| 285 | ZNTL | Zentalis Pharmaceuticals, Inc. | 286.86M | -2.57% | 675,557 | 26.87M |
| 286 | GLSI | Greenwich LifeSciences, Inc. | 272.94M | -2.08% | 110,116 | - |
| 287 | SION | Sionna Therapeutics, Inc. | 271.27M | 0.67% | 2,522,926 | - |
| 288 | STRO | Sutro Biopharma, Inc. | 271.10M | 6.58% | 320,319 | 45.70M |
| 289 | LYEL | Lyell Immunopharma, Inc. | 267.84M | -0.73% | 142,619 | 27.00K |
| 290 | PYXS | Pyxis Oncology, Inc. | 266.07M | -4.20% | 633,189 | 11.04M |
| 291 | ACIU | AC Immune SA | 263.98M | 0.95% | 109,422 | 21.67M |
| 292 | YARW | Yarrow Bioscience, Inc. | 263.31M | -3.38% | 134,995 | - |
| 293 | PRQR | ProQR Therapeutics N.V. | 262.49M | 1.64% | 407,252 | 21.05M |
| 294 | MGNX | MacroGenics, Inc. | 262.44M | -0.48% | 310,494 | 175.14M |
| 295 | CAMP | Camp4 Therapeutics Corporation | 261.68M | -1.65% | 289,473 | 4.22M |
| 296 | LCTX | Lineage Cell Therapeutics, Inc. | 255.44M | -1.94% | 730,633 | 13.08M |
| 297 | BCYC | Bicycle Therapeutics plc | 254.07M | -0.55% | 266,518 | 61.21M |
| 298 | FHTX | Foghorn Therapeutics Inc. | 246.45M | 0.24% | 188,398 | 36.74M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 240.23M | -1.12% | 61,363 | 1.48M |
| 300 | TRDA | Entrada Therapeutics, Inc. | 239.42M | -1.63% | 375,282 | 4.69M |
| 301 | CGEN | Compugen Ltd. | 230.65M | -2.21% | 217,392 | 74.00M |
| 302 | WHWK | Whitehawk Therapeutics, Inc. | 230.32M | -3.81% | 389,575 | 7.15M |
| 303 | ALXO | ALX Oncology Holdings Inc. | 229.54M | -2.35% | 849,506 | - |
| 304 | KROS | Keros Therapeutics, Inc. | 227.62M | 2.59% | 120,719 | 15.01M |
| 305 | AVXL | Anavex Life Sciences Corp. | 222.47M | -0.83% | 574,474 | - |
| 306 | PLX | Protalix BioTherapeutics, Inc. | 221.57M | 2.23% | 471,379 | 80.62M |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 218.81M | 2.67% | 609,849 | - |
| 308 | ADAG | Adagene Inc. | 215.53M | -3.02% | 97,767 | 9.29M |
| 309 | ALEC | Alector, Inc. | 215.50M | 1.05% | 1,281,184 | 13.86M |
| 310 | NGEN | NervGen Pharma Corp. | 213.97M | -2.93% | 473,668 | - |
| 311 | CHRS | Coherus Oncology, Inc. | 211.67M | 1.48% | 1,489,464 | 50.94M |
| 312 | TARA | Protara Therapeutics, Inc. | 207.43M | -1.13% | 735,464 | - |
| 313 | NKTX | Nkarta, Inc. | 206.28M | 1.77% | 385,791 | - |
| 314 | CUE | Cue Biopharma, Inc. | 205.36M | -23.70% | 3,540,709 | 37.66M |
| 315 | VRXA | Veraxa Biotech AG | 200.80M | -2.74% | 49,264 | 29.54K |
| 316 | PEPG | PepGen Inc. | 196.70M | -0.35% | 652,361 | - |
| 317 | ORMP | Oramed Pharmaceuticals Inc. | 195.51M | -0.84% | 98,046 | 2.00M |
| 318 | ACOG | Alpha Cognition Inc. | 195.35M | 1.81% | 92,267 | 15.26M |
| 319 | MSLE | Satellos Bioscience Inc. | 194.74M | -1.50% | 11,240 | - |
| 320 | CNTN | Canton Strategic Holdings, Inc. | 194.42M | 6.09% | 799,966 | 1.50M |
| 321 | SRZN | Surrozen, Inc. | 194.29M | -0.12% | 129,007 | 11.51M |
| 322 | SLGL | Sol-Gel Technologies Ltd. | 194.08M | -1.20% | 29,772 | 1.80M |
| 323 | VYGR | Voyager Therapeutics, Inc. | 189.78M | -0.32% | 292,670 | 34.46M |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 187.30M | -2.26% | 395,148 | - |
| 325 | ANTX | AN2 Therapeutics, Inc. | 187.17M | -1.78% | 305,213 | - |
| 326 | NBP | NovaBridge Biosciences | 186.76M | 0.63% | 243,563 | - |
| 327 | YDES | YD Bio Limited | 186.29M | -17.55% | 662,568 | 1.24M |
| 328 | TNXP | Tonix Pharmaceuticals Holding Corp. | 183.86M | -1.38% | 524,912 | 29.10M |
| 329 | DTIL | Precision BioSciences, Inc. | 179.41M | -2.55% | 272,319 | 45.06M |
| 330 | NERV | Minerva Neurosciences, Inc. | 175.95M | 0.68% | 148,570 | - |
| 331 | MDWD | MediWound Ltd. | 171.84M | -0.67% | 72,406 | 11.86M |
| 332 | IPHA | Innate Pharma S.A. | 167.61M | -2.11% | 77,038 | 11.21M |
| 333 | OTLK | Outlook Therapeutics, Inc. | 167.08M | 5.16% | 2,877,699 | -1.16M |
| 334 | HUMA | Humacyte, Inc. | 163.90M | 0.75% | 3,406,322 | 2.12M |
| 335 | MNOV | MediciNova, Inc. | 162.43M | -0.60% | 668,514 | 920.48K |
| 336 | MENS | Jyong Biotech Ltd. | 159.60M | 4.37% | 138,946 | - |
| 337 | MOLN | Molecular Partners AG | 158.60M | -5.23% | 4,020 | 856.30K |
| 338 | ARMP | Armata Pharmaceuticals, Inc. | 158.40M | 1.91% | 82,899 | 5.54M |
| 339 | RNA | Atrium Therapeutics, Inc. | 157.20M | 2.68% | 481,254 | 35.84M |
| 340 | SPRB | Spruce Biosciences, Inc. | 154.33M | 1.23% | 97,023 | 697.00K |
| 341 | CDXS | Codexis, Inc. | 151.12M | 1.47% | 539,559 | 77.68M |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 151.09M | -0.81% | 3,944,904 | 1.34M |
| 343 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 147.96M | 2.27% | 499,816 | - |
| 344 | IMUX | Immunic, Inc. | 147.77M | 1.98% | 468,622 | - |
| 345 | KRRO | Korro Bio, Inc. | 146.96M | -0.40% | 290,492 | 2.38M |
| 346 | KZIA | Kazia Therapeutics Limited | 145.94M | 2.50% | 193,450 | 1.27M |
| 347 | NRXP | NRx Pharmaceuticals, Inc. | 142.33M | -0.90% | 379,910 | 3.39M |
| 348 | CRBU | Caribou Biosciences, Inc. | 139.37M | - | 753,310 | 10.04M |
| 349 | HURA | TuHURA Biosciences, Inc. | 138.92M | 3.81% | 237,200 | - |
| 350 | CNXU | Conexeu Sciences Inc. | 133.98M | -4.23% | 138,287 | - |
| 351 | UNCY | Unicycive Therapeutics, Inc. | 132.87M | -0.63% | 448,425 | - |
| 352 | ENGN | enGene Therapeutics Inc. | 131.35M | 2.62% | 426,322 | - |
| 353 | NMRA | Neumora Therapeutics, Inc. | 129.99M | -5.23% | 1,675,812 | - |
| 354 | MIST | Milestone Pharmaceuticals Inc. | 129.33M | 0.22% | 673,940 | 2.34M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 128.21M | - | 2,723,325 | 65.34K |
| 356 | LENZ | LENZ Therapeutics, Inc. | 128.19M | 0.25% | 776,631 | 21.48M |
| 357 | BMEA | Biomea Fusion, Inc. | 123.95M | -6.56% | 1,785,853 | - |
| 358 | OKUR | OnKure Therapeutics, Inc. | 123.92M | 3.73% | 166,719 | - |
| 359 | PMN | ProMIS Neurosciences, Inc. | 122.23M | -2.71% | 26,238 | - |
| 360 | AARD | Aardvark Therapeutics, Inc. | 121.90M | 3.53% | 110,292 | - |
| 361 | NAUT | Nautilus Biotechnology, Inc. | 121.49M | -1.17% | 737,896 | 190.00K |
| 362 | EQ | Equillium, Inc. | 120.16M | -1.30% | 266,454 | 4.39M |
| 363 | CBUS | Cibus, Inc. | 119.23M | -3.11% | 70,015 | 4.35M |
| 364 | TLSA | Tiziana Life Sciences Ltd | 116.97M | -0.11% | 534,913 | - |
| 365 | COYA | Coya Therapeutics, Inc. | 116.12M | 1.23% | 167,175 | 8.02M |
| 366 | GNLX | Genelux Corporation | 114.72M | 1.19% | 197,285 | 8.00K |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 112.03M | -0.51% | 827,277 | 70.00M |
| 368 | VANI | Vivani Medical, Inc. | 111.85M | 4.20% | 131,876 | - |
| 369 | PMVP | PMV Pharmaceuticals, Inc. | 111.38M | -1.67% | 329,929 | - |
| 370 | CLLS | Cellectis S.A. | 110.39M | -1.31% | 90,041 | 63.82M |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 110.04M | -8.42% | 681,298 | 4.88M |
| 372 | TENX | Tenax Therapeutics, Inc. | 107.69M | -1.05% | 2,141,291 | - |
| 373 | PLYX | Polaryx Therapeutics, Inc. | 106.67M | 4.90% | 32,084 | - |
| 374 | CRDF | Cardiff Oncology, Inc. | 106.58M | - | 475,829 | 508.00K |
| 375 | PYPD | PolyPid Ltd. | 105.01M | -0.77% | 40,642 | - |
| 376 | SEER | Seer, Inc. | 102.99M | - | 86,601 | 14.22M |
| 377 | ONCY | Oncolytics Biotech Inc. | 97.71M | -0.48% | 697,380 | - |
| 378 | ACET | Adicet Bio, Inc. | 96.13M | -2.72% | 49,786 | - |
| 379 | CGTX | Cognition Therapeutics, Inc. | 95.09M | -3.85% | 769,758 | - |
| 380 | NTRB | Nutriband Inc. | 94.45M | -4.43% | 135,104 | 1.62M |
| 381 | ATRA | Atara Biotherapeutics, Inc. | 94.15M | -3.20% | 29,670 | 6.19M |
| 382 | ANIX | Anixa Biosciences, Inc. | 93.86M | -2.53% | 476,242 | - |
| 383 | ICCC | ImmuCell Corporation | 92.00M | 1.81% | 3,184 | 30.68M |
| 384 | GUTS | Fractyl Health, Inc. | 91.00M | -4.72% | 685,295 | 3.00K |
| 385 | RLYB | Rallybio Corporation | 89.91M | -1.51% | 7,915 | 646.00K |
| 386 | NRXS | NeurAxis, Inc. | 89.66M | -6.18% | 111,052 | 5.32M |
| 387 | PTHS | Pelthos Therapeutics Inc. | 88.63M | 2.21% | 16,709 | 43.30M |
| 388 | ACRV | Acrivon Therapeutics, Inc. | 86.14M | 8.65% | 333,908 | - |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 85.28M | 0.81% | 46,361 | - |
| 390 | CNTB | Connect Biopharma Holdings Limited | 83.13M | 3.13% | 1,355,285 | 2.95M |
| 391 | NTHI | NeOnc Technologies Holdings, Inc. | 82.77M | 2.15% | 136,148 | 39.99K |
| 392 | ALDX | Aldeyra Therapeutics, Inc. | 81.44M | -0.74% | 495,069 | - |
| 393 | IBIO | iBio, Inc. | 81.03M | -1.56% | 389,438 | 100.00K |
| 394 | MAIA | MAIA Biotechnology, Inc. | 80.90M | 1.53% | 1,142,493 | - |
| 395 | FBIO | Fortress Biotech, Inc. | 80.38M | -3.98% | 283,242 | 68.47M |
| 396 | GANX | Gain Therapeutics, Inc. | 80.30M | 4.55% | 335,806 | - |
| 397 | OSTX | OS Therapies Incorporated | 80.26M | -1.69% | 637,059 | - |
| 398 | BSEM | BioStem Technologies, Inc. | 78.54M | -7.17% | 237,727 | 34.59M |
| 399 | KLRS | Kalaris Therapeutics, Inc. | 77.25M | 1.41% | 88,631 | - |
| 400 | VRCA | Verrica Pharmaceuticals Inc. | 77.13M | 0.90% | 29,572 | 30.32M |
| 401 | CING | Cingulate Inc. | 76.05M | -0.19% | 75,479 | - |
| 402 | RNXT | RenovoRx, Inc. | 75.37M | -1.18% | 477,900 | 1.98M |
| 403 | CSBR | Champions Oncology, Inc. | 73.21M | -0.75% | 10,391 | 60.66M |
| 404 | OKYO | OKYO Pharma Limited | 69.80M | -2.21% | 127,943 | - |
| 405 | ELOX | Eloxx Pharmaceuticals, Inc. | 69.39M | -1.49% | 22,345 | - |
| 406 | HYFT | MindWalk Holdings Corp. | 69.07M | 8.09% | 714,372 | 11.57M |
| 407 | GOSS | Gossamer Bio, Inc. | 68.93M | 5.13% | 258,790 | 53.29M |
| 408 | PLRX | Pliant Therapeutics, Inc. | 68.73M | - | 149,281 | - |
| 409 | RNTX | Rein Therapeutics Inc. | 68.54M | -0.69% | 178,151 | - |
| 410 | ATHE | Alterity Therapeutics Limited | 67.60M | -3.32% | 11,400 | 2.50M |
| 411 | XBIT | XBiotech Inc. | 66.62M | -0.23% | 31,837 | - |
| 412 | ALPS | Alps Group Inc | 66.56M | - | 66,468 | 3.74M |
| 413 | SPRO | Spero Therapeutics, Inc. | 66.39M | 0.88% | 319,093 | 47.00M |
| 414 | BOLD | Boundless Bio, Inc. | 64.37M | 0.71% | 133,702 | - |
| 415 | INMB | INmune Bio Inc. | 63.56M | -1.72% | 306,634 | 50.00K |
| 416 | INKT | MiNK Therapeutics, Inc. | 62.51M | 1.66% | 8,030 | - |
| 417 | IBO | Impact BioMedical Inc. | 59.92M | -5.81% | 91,107 | 35.00K |
| 418 | HYPD | Hyperion DeFi, Inc. | 59.83M | -1.79% | 716,977 | 1.40M |
| 419 | LONA | LeonaBio, Inc. | 59.64M | -6.77% | 45,592 | - |
| 420 | XLO | Xilio Therapeutics, Inc. | 59.35M | -1.20% | 7,132 | 64.09M |
| 421 | SER | Serina Therapeutics, Inc. | 58.68M | 2.67% | 30,977 | 130.00K |
| 422 | CLNN | Clene Inc. | 58.33M | 4.37% | 109,705 | 197.00K |
| 423 | EXOZ | eXoZymes, Inc. | 56.71M | -5.12% | 12,413 | -700.00 |
| 424 | EDSA | Edesa Biotech, Inc. | 55.53M | -0.72% | 41,979 | - |
| 425 | IMA | ImageneBio, Inc. | 54.60M | -1.64% | 23,921 | 800.00K |
| 426 | DWTX | Dogwood Therapeutics, Inc. | 54.39M | -5.33% | 61,681 | - |
| 427 | APLM | Apollomics, Inc. | 52.51M | 2.09% | 2,839 | 8.84M |
| 428 | HRTX | Heron Therapeutics, Inc. | 51.26M | -12.82% | 8,585,585 | 151.18M |
| 429 | ANVS | Annovis Bio, Inc. | 50.70M | 4.39% | 885,901 | - |
| 430 | ELTX | Elicio Therapeutics, Inc. | 50.20M | 1.06% | 484,462 | - |
| 431 | TVGN | Tevogen Inc. | 48.38M | -4.87% | 1,771 | - |
| 432 | TIL | Instil Bio, Inc. | 47.95M | -0.28% | 69,053 | - |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 47.63M | 1.55% | 476,569 | 21.00M |
| 434 | PDSB | PDS Biotechnology Corporation | 47.12M | 4.52% | 17,073,075 | - |
| 435 | MREO | Mereo BioPharma Group plc | 46.33M | -4.26% | 1,929,661 | 500.00K |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.18M | -0.47% | 109,938 | - |
| 437 | LITS | Lite Strategy, Inc. | 43.55M | 13.27% | 1,610,092 | - |
| 438 | MGX | Metagenomi Therapeutics, Inc. | 42.31M | 1.82% | 103,274 | 13.56M |
| 439 | KPTI | Karyopharm Therapeutics Inc. | 42.19M | -1.06% | 1,624,700 | 146.62M |
| 440 | IMMP | Immutep Limited | 41.99M | 1.25% | 358,254 | 13.79M |
| 441 | VERU | Veru Inc. | 41.60M | 1.24% | 158,316 | 16.89M |
| 442 | MCRB | Seres Therapeutics, Inc. | 40.46M | 1.75% | 38,806 | 1.88M |
| 443 | NNVC | NanoViricides, Inc. | 38.50M | 19.01% | 1,689,534 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 37.73M | -1.64% | 99,376 | 35.09M |
| 445 | ATYR | aTyr Pharma, Inc. | 36.57M | 2.70% | 918,660 | 190.00K |
| 446 | CRVO | CervoMed Inc. | 36.44M | -0.82% | 109,101 | 331.30K |
| 447 | BCTX | BriaCell Therapeutics Corp. | 35.99M | -1.43% | 167,640 | - |
| 448 | CELU | Celularity Inc. | 35.89M | -5.34% | 213,983 | 26.55M |
| 449 | FLNA | Filana Therapeutics, Inc. | 35.72M | 1.86% | 339,712 | - |
| 450 | CNTX | Context Therapeutics Inc. | 34.42M | 1.77% | 770,213 | - |
| 451 | ALGS | Aligos Therapeutics, Inc. | 34.28M | 4.77% | 125,043 | 31.52M |
| 452 | QNRX | Quoin Pharmaceuticals, Ltd. | 33.15M | -2.27% | 52,075 | - |
| 453 | QNCX | Quince Therapeutics, Inc. | 31.53M | 5.16% | 13,675 | - |
| 454 | BYSI | BeyondSpring Inc. | 30.43M | -1.31% | 31,994 | 1.88M |
| 455 | ABVC | ABVC BioPharma, Inc. | 29.81M | -0.86% | 236,486 | 797.92K |
| 456 | RNAZ | TransCode Therapeutics, Inc. | 29.80M | 6.67% | 66,009 | - |
| 457 | CVM | CEL-SCI Corporation | 29.37M | 0.60% | 110,188 | - |
| 458 | QNTM | Quantum BioPharma Ltd. | 29.20M | -1.37% | 78,328 | - |
| 459 | KYNB | Kyntra Bio, Inc. | 29.15M | 1.69% | 18,455 | 4.62M |
| 460 | IGC | IGC Pharma, Inc. | 28.33M | -3.86% | 509,551 | 1.11M |
| 461 | EVAX | Evaxion A/S | 26.77M | -1.83% | 36,722 | 7.49M |
| 462 | PLRZ | Polyrizon Ltd. | 26.18M | -0.82% | 14,801 | - |
| 463 | NXTC | NextCure, Inc. | 24.99M | -10.78% | 126,033 | - |
| 464 | PBM | Psyence Biomedical Ltd. | 24.87M | -1.66% | 91,304 | - |
| 465 | GRDX | GridAI Technologies Corp. | 24.08M | 9.32% | 52,902 | - |
| 466 | COCP | Cocrystal Pharma, Inc. | 23.40M | 0.41% | 41,131 | 330.00K |
| 467 | ATOS | Atossa Therapeutics, Inc. | 22.45M | 1.35% | 67,144 | - |
| 468 | TCRX | TScan Therapeutics, Inc. | 22.41M | 6.00% | 756,918 | 7.11M |
| 469 | CLRB | Cellectar Biosciences, Inc. | 22.21M | -1.26% | 50,008 | - |
| 470 | ESLA | Estrella Immunopharma, Inc. | 21.84M | -5.07% | 51,958 | - |
| 471 | ACTU | Actuate Therapeutics, Inc. | 21.79M | -7.53% | 275,522 | - |
| 472 | RADX | Radiopharm Theranostics Limited | 21.63M | -2.42% | 35,968 | 9.34M |
| 473 | TVRD | Tvardi Therapeutics, Inc. | 21.48M | -1.23% | 186,730 | - |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 20.08M | 0.27% | 17,851 | 1.17M |
| 475 | JSPR | Jasper Therapeutics, Inc. | 20.05M | -2.44% | 209,334 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 20.01M | 2.12% | 23,854 | 3.55M |
| 477 | PTN | Palatin Technologies, Inc. | 19.47M | -5.89% | 57,774 | 12.88M |
| 478 | LTRN | Lantern Pharma Inc. | 19.18M | -3.23% | 248,508 | - |
| 479 | ALLR | Allarity Therapeutics, Inc. | 18.62M | -3.31% | 115,117 | 345.00K |
| 480 | LPCN | Lipocine Inc. | 18.47M | 1.36% | 16,696 | 1.57M |
| 481 | AKTX | Akari Therapeutics, Plc | 18.26M | 2.40% | 18,698 | - |
| 482 | CMMB | Chemomab Therapeutics Ltd. | 17.97M | -4.98% | 83,556 | - |
| 483 | NCEL | NewcelX Ltd. | 17.16M | -5.71% | 11,985 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 17.05M | -2.54% | 67,810 | - |
| 485 | KPRX | Kiora Pharmaceuticals, Inc. | 17.05M | -2.90% | 6,083 | 20.00K |
| 486 | BCDA | BioCardia, Inc. | 16.35M | -7.69% | 2,080,379 | 3.00K |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 15.83M | -3.92% | 155,876 | 7.11M |
| 488 | ICU | SeaStar Medical Holding Corporation | 15.78M | 1.13% | 22,484 | 1.71M |
| 489 | PASG | Passage Bio, Inc. | 15.25M | -0.21% | 111,383 | - |
| 490 | DYAI | Dyadic International, Inc. | 14.61M | -3.37% | 90,322 | 3.80M |
| 491 | NIKI | Niki BioSolutions, Inc. | 14.60M | 5.30% | 18,816 | - |
| 492 | CNSY | Cerenome, Inc. | 14.42M | -6.40% | 112,261 | 4.20M |
| 493 | LSTA | Lisata Therapeutics, Inc. | 14.06M | -8.24% | 228,271 | 100.00K |
| 494 | HIND | Vyome Holdings, Inc. | 13.55M | -8.10% | 62,876 | 129.73K |
| 495 | PLUR | Pluri Inc. | 13.21M | -0.93% | 8,297 | 1.02M |
| 496 | INTS | Intensity Therapeutics, Inc. | 13.12M | -2.19% | 6,356 | - |
| 497 | GTBP | GT Biopharma, Inc. | 12.96M | 0.28% | 57,706 | - |
| 498 | TPST | Tempest Therapeutics, Inc. | 12.80M | -20.06% | 1,899,846 | - |
| 499 | CALC | CalciMedica, Inc. | 12.70M | -3.12% | 50,385 | - |
| 500 | AEON | AEON Biopharma, Inc. | 12.67M | 4.74% | 666,349 | - |